PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26024F0282XYWAV ORAL solution — Jazz Pharmaceuticals, Inc

Jazz Pharmaceuticals, Inc holds $4.5M across 57 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 3 related awards under parent 36F79719D0205. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Mar 8, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

260-Network Contract Office 20 (36C260)
Awarding office
Jazz Pharmaceuticals, Inc
Recipient
Mar 8, 2025
PoP end
$147K
Obligated
$246K
Potential
325412
NAICS
6505
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Jazz Pharmaceuticals, Inc — $90

Contract facts

Federal
Contract number36C26024F0282
Also listed as36C260-24-F-0282
Also listed as36F79719D0205-36C26024F0282
Agency260-Network Contract Office 20 (36C260)
Awarding office260-Network Contract Office 20 (36C260)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentJazz Pharmaceuticals, Inc
CAGE4RTH5
UEIH9AXCNRA5NE6
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79719D0205
Place of performanceSAINT LOUIS MO
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startMar 8, 2024
PoP end (current)Mar 8, 2025
Obligated$147K
Current value$246K
Potential value$246K

XYWAV ORAL SOLUTION is a federal award for 260-Network Contract Office 20 (36C260) held by Jazz Pharmaceuticals, Inc. Estimated value $246K ($147K obligated). Current period of performance ends Mar 8, 2025. Last award drew 1 bidder. Place of performance: SAINT LOUIS MO.

Recompete timing

Public
Past PoP end (531 days ago)

Current PoP ended Mar 8, 2025 (531 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Jazz Pharmaceuticals, Inc$4.5M obligated across 57 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)
Department of Veterans Affairs (VA)$4.5M · 100% of firm total
Open full company profile

Related awards

Same parent · incumbent
36C26026F0027
XYWAV 500MG/ML ORAL SOLUTION, AND XYREM 500MG/ML ORAL SOLUTION
$456K
Sep 30, 2026
36C26026F0013
PHARM - XYWAV
$240K
Sep 30, 2026
36C26026F0012
PHARM - XYREM
$210K
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26024F0282?

36C26024F0282 (XYWAV ORAL solution) is a 260-Network Contract Office 20 (36C260) award with a potential value of $246K, currently held by Jazz Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C260-24-F-0282?

36C260-24-F-0282 is the dashed form of PIID 36C26024F0282 (XYWAV ORAL solution), held by Jazz Pharmaceuticals, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26024F0282?

260-Network Contract Office 20 (36C260) awarded 36C26024F0282 to Jazz Pharmaceuticals, Inc (potential $246K).

Who is the incumbent on 36C26024F0282?

Jazz Pharmaceuticals, Inc is the incumbent with $4.5M across 57 related awards in SCOUT’s public footprint. The current period of performance ends Mar 8, 2025.

When does Jazz Pharmaceuticals, Inc’s 36C26024F0282 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 8, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26024F0282